4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Reperfusion Injury in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuya, H; Horiuchi, T; Inoue, S; Kawaguchi, M; Konishi, N; Kurita, N; Nakamura, M; Sakamoto, T | 1 |
1 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Reperfusion Injury
| Article | Year |
|---|---|
The effects of the delta-opioid agonist SNC80 on hind-limb motor function and neuronal injury after spinal cord ischemia in rats.
Topics: Animals; Benzamides; Blood Gas Analysis; Body Temperature; Hindlimb; Injections, Spinal; Male; Movement; Neurons; Neuroprotective Agents; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reperfusion Injury; Spinal Cord Ischemia | 2004 |